Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synapix was a medical technology company specializing in advanced 3D image processing and computer vision software for healthcare applications. Spun off from the University of Leuven (KU Leuven) and the research institute IMEC, the company developed sophisticated algorithms for the reconstruction and analysis of medical images. Its technology was primarily utilized in the dental and orthopedic sectors to assist in surgical planning and the creation of patient-specific anatomical models. Synapix was acquired by Materialise in 2004, where its core technologies were integrated into Materialise's medical software suite to enhance 3D visualization and surgical simulation capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SynaPix.